NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

OpenAI Feud: Musk and Altman Face Scrutiny in Court Testimony

A high-stakes court battle between Elon Musk and Sam Altman, two of the world's leading tech entrepreneurs, has taken a dramatic turn as a jury waded deeper into their bitter OpenAI feud. The trial, which is revisiting the startup's tumultuous 11-year history, has boiled down to a credibility contest over who is wronging whom, with both sides trading blows in court testimony.

A Tumultuous History

OpenAI, founded in 2015 with the goal of benefiting humanity, has grown into a behemoth valued at almost $1 trillion. However, the relationship between Musk and Altman, who were once co-founders, has been strained for years. The tension came to a head in 2017, when a power struggle broke out and Brockman, OpenAI's president, testified that Musk lacked the technical competency to oversee the development of artificial intelligence. Brockman also recounted a tense moment in August 2017 when Musk grew angry and stormed out of the room after a disagreement.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

YearMusk's InvolvementAltman's Involvement
2015Co-founderCo-founder
2017Power struggle breaks outTakes over as CEO
2018Leaves OpenAI boardBecomes sole CEO
2023Briefly ousted as CEOReinstated as CEO

Criticisms Mount

Brockman was not the only one to criticize Musk's leadership style. Mira Murati, OpenAI's former chief technology officer, testified that Musk "created chaos" among top executives and did not always tell the truth. Murati also accused Altman of undermining her and not being honest in his communications with the board. Former OpenAI board members Helen Toner and Tasha McCauley echoed these sentiments, describing a "toxic culture of lying" and a "pattern of behavior related to his honesty, candor, and resistance to board oversight."

The Trial Continues

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

The trial is expected to wrap up on Thursday, with Altman scheduled to testify next week. The jury will have to weigh the credibility of both sides and decide who is telling the truth. US District Judge Yvonne Gonzalez Rogers has acknowledged that the case is more about trustworthiness than it is about a smoking-gun corporate document or legal contract. "This trial, like many trials, boils down to who the jurors are going to believe," she said Thursday.

The outcome of the trial will have significant implications for OpenAI and its future direction. With both sides trading blows, it remains to be seen who will emerge victorious in this high-stakes battle.

Investor Takeaway

Investors should be cautious of leadership styles and trustworthiness when evaluating tech companies.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.